Bath & Body Works (NYSE:BBWI) Given “Outperform” Rating at Telsey Advisory Group

Telsey Advisory Group reissued their outperform rating on shares of Bath & Body Works (NYSE:BBWI) in a report issued on Thursday morning, Benzinga reports. Telsey Advisory Group currently has a $42.00 target price on the stock.

A number of other research firms also recently weighed in on BBWI. Piper Sandler decreased their target price on shares of Bath & Body Works from $47.00 to $39.00 and set a neutral rating for the company in a research report on Thursday, July 11th. Citigroup dropped their price target on shares of Bath & Body Works from $48.00 to $35.00 and set a neutral rating on the stock in a research report on Tuesday, August 20th. JPMorgan Chase & Co. decreased their price objective on shares of Bath & Body Works from $42.00 to $39.00 and set a neutral rating for the company in a research report on Thursday, August 29th. UBS Group dropped their target price on shares of Bath & Body Works from $52.00 to $38.00 and set a neutral rating on the stock in a report on Thursday, August 29th. Finally, Morgan Stanley reduced their price target on Bath & Body Works from $56.00 to $51.00 and set an overweight rating for the company in a report on Thursday, September 5th. Eight research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, Bath & Body Works currently has an average rating of Moderate Buy and an average price target of $42.35.

Bath & Body Works Price Performance

BBWI stock opened at $32.39 on Thursday. The stock has a market capitalization of $7.23 billion, a P/E ratio of 8.35, a P/E/G ratio of 0.96 and a beta of 1.77. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The business has a 50-day moving average of $31.85 and a 200-day moving average of $40.24.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. Equities analysts expect that Bath & Body Works will post 3.18 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.47%. The ex-dividend date was Friday, August 23rd. Bath & Body Works’s dividend payout ratio is 20.62%.

Institutional Investors Weigh In On Bath & Body Works

A number of hedge funds and other institutional investors have recently modified their holdings of BBWI. First Community Trust NA bought a new position in Bath & Body Works during the second quarter worth about $30,000. GAMMA Investing LLC raised its position in shares of Bath & Body Works by 75.7% in the first quarter. GAMMA Investing LLC now owns 1,116 shares of the company’s stock valued at $56,000 after buying an additional 481 shares in the last quarter. EntryPoint Capital LLC boosted its stake in shares of Bath & Body Works by 224.0% in the first quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock valued at $74,000 after buying an additional 1,017 shares during the period. TFO Wealth Partners LLC grew its position in Bath & Body Works by 9,664.7% during the fourth quarter. TFO Wealth Partners LLC now owns 1,660 shares of the company’s stock worth $72,000 after buying an additional 1,643 shares in the last quarter. Finally, Quarry LP increased its stake in Bath & Body Works by 289.4% during the 4th quarter. Quarry LP now owns 1,690 shares of the company’s stock worth $73,000 after acquiring an additional 1,256 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.